HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

2',3'-Didehydro-2',3'-dideoxyadenosine

HCID 64975
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
7057-48-9
Standard SMILES
Nc1ncnc2c1ncn2[C@H]1C=C[C@@H](CO)O1
InChIKey
JFUOUIPRAAGUGF-NKWVEPMBSA-N
Molecular formula
C10H11N5O2
Average molar mass
233.23 g/mol
Monoisotopic mass
233.09127461

Overview

structure given in first source

Names & identifiers

Preferred name
2',3'-Didehydro-2',3'-dideoxyadenosine
IUPAC
[(2S,5R)-5-(6-aminopurin-9-yl)-2,5-dihydrofuran-2-yl]methanol
English name
2',3'-Dideoxy-2',3'-didehydroadenosine
Molecular formula
C10H11N5O2
Molecular weight
233.23

Names & synonyms

7057-48-92'3'-Didehydro-2'3'-dideoxyadenosine2'3'-Ddda2',3'-Didehydro-2',3'-dideoxyadenosineSK35877HI5RefChem:908366beta-L-D4A2',3'-Dideoxy-2',3'-didehydroadenosine((2S,5R)-5-(6-Amino-9H-purin-9-yl)-2,5-dihydrofuran-2-yl)methanolAdenosine, 2',3'-didehydro-2',3'-dideoxy-[(2S,5R)-5-(6-amino-9H-purin-9-yl)-2,5-dihydrofuran-2-yl]methanol2',3'-Dideoxy-2'3'-didehydroadenosine
Show more names
D4ANSC 108602Compound FL0097Didanosin EP Imp I2',3'-Dideoxy-2'3'-didehy...
[(2S,5R)-5-(6-aminopurin-9-yl)-2,5-dihydrofuran-2-yl]methanolDidanosine EP Impurity IMFCD00040965ddeAdoAdenine, 9-(2,3-dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)-UNII-SK35877HI5NSC108602NSC-108602

Database identifiers

CAS
7057-48-9

Properties

Computed structural properties

XLogP
-0.4
Topological polar surface area
99.1 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
2
Heavy atoms
17
Formal charge
0
Complexity
313

Experimental & physicochemical properties

LogP-0.36

Physicochemical properties

Melting point
187 · 187-189°C
Boiling point
553.9 · 553.9±60.0 °C(Predicted)
Density
1.74 · 1.74±0.1 g/cm3(Predicted)
storage temp.
2 · 2-8°C(protect from light)
solubility
Soluble in DMSO
pka
14.28 · 14.28±0.10(Predicted)
Appearance
white solid
FDA UNII
35877 HI5 · SK35877HI5
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
280 · P280-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302
Precautionary statements
P280-P305+P351+P338

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 3 items

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.

Applications · 1 item

Uses2’,3’-Dideoxy-2,3-didehydroadenosine (Didanosine EP Impurity I) is an impurity of Didanosine (D440950), which is a purine analog (1) which used as an antiviral agent. Classed as an anti-retroviral drug used in the treatment of HIV in ART therapy, it also may increase acetaminophen related hepatotoxicity by enhancing mitochrondrial dysfunction (2).

Related reactions

2 records
New reaction record
HRID 2209753 reaction equation
HRID 2209753As product
HRID 2209754 reaction equation
HRID 2209754As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
64975
DTXSID
DTXSID70875924
ChEMBL
CHEMBL290427
UNII
SK35877HI5
Nikkaji
J152.165I